Literature DB >> 20158474

Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.

Y Y Li1, T J Hou, W A Goddard.   

Abstract

G protein-coupled receptors (GPCRs) mediate senses such as odor, taste, vision, and pain in mammals. In addition, important cell recognition and communication processes often involve GPCRs. Many diseases involve malfunction of GPCRs, making them important targets for drug development. Indeed, greater than 50 % of all marketed therapeutics act on those receptors. Unfortunately, the atomic-level structures are only available for rhodopsin, beta2AR, beta1AR, A2A adenosin and opsin. In silico computational methods, employing receptor-based modeling, offer a rational approach in the design of drugs targeting GPCRs. These approaches can be used to understand receptor selectivity and species specificity of drugs that interact with GPCRs. This review gives an overview of current computational approaches to GPCR model building; ligand-receptor interaction for drug design; and molecular mechanism of GPCR activation from simulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20158474     DOI: 10.2174/092986710790827807

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  14 in total

1.  Selectivity and activation of dopamine D3R from molecular dynamics.

Authors:  Zhiwei Feng; Tingjun Hou; Youyong Li
Journal:  J Mol Model       Date:  2012-07-03       Impact factor: 1.810

Review 2.  Therapeutic antibodies directed at G protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; Fiona H Marshall
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

3.  Detecting local ligand-binding site similarity in nonhomologous proteins by surface patch comparison.

Authors:  Lee Sael; Daisuke Kihara
Journal:  Proteins       Date:  2012-01-24

4.  Structural signatures of DRD4 mutants revealed using molecular dynamics simulations: Implications for drug targeting.

Authors:  Nidhi Jatana; Lipi Thukral; N Latha
Journal:  J Mol Model       Date:  2015-12-17       Impact factor: 1.810

5.  Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.

Authors:  Xingyu Lin; Xi-Ping Huang; Gang Chen; Ryan Whaley; Shiming Peng; Yanli Wang; Guoliang Zhang; Simon X Wang; Shaohui Wang; Bryan L Roth; Niu Huang
Journal:  J Med Chem       Date:  2012-06-19       Impact factor: 7.446

Review 6.  Progress in structure based drug design for G protein-coupled receptors.

Authors:  Miles Congreve; Christopher J Langmead; Jonathan S Mason; Fiona H Marshall
Journal:  J Med Chem       Date:  2011-06-15       Impact factor: 7.446

7.  Prediction of functionally important residues in globular proteins from unusual central distances of amino acids.

Authors:  Marek Kochańczyk
Journal:  BMC Struct Biol       Date:  2011-09-18

8.  Biophysical mapping of the adenosine A2A receptor.

Authors:  Andrei Zhukov; Stephen P Andrews; James C Errey; Nathan Robertson; Benjamin Tehan; Jonathan S Mason; Fiona H Marshall; Malcolm Weir; Miles Congreve
Journal:  J Med Chem       Date:  2011-06-10       Impact factor: 7.446

9.  Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.

Authors:  Bing Han; Yan-Yan Zhang; Ze-Qing Ye; Yun Xiao; Javad Rasouli; Wen-Cheng Wu; Su-Min Ye; Xin-Yue Guo; Lin Zhu; Abdolmohamad Rostami; Li-Bin Wang; Yuan Zhang; Xing Li
Journal:  Immunology       Date:  2021-02-28       Impact factor: 7.215

Review 10.  G-protein coupled receptors: advances in simulation and drug discovery.

Authors:  Yinglong Miao; J Andrew McCammon
Journal:  Curr Opin Struct Biol       Date:  2016-06-22       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.